^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Equidacent (bevacizumab biosimilar)

    i
    Associations
    News

    Trials

    Company:
    AstraZeneca, Centus Biotherap, Fujifilm Kyowa Kirin Biologics
    Drug class:
    VEGF-A inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Tri Association in Patient With Advanced Epithelial Ovarian Cancer in Relapse (BOLD) (NCT04015739)
    Phase 2
    ARCAGY/ GINECO GROUP
    Active, not recruiting
    Last update posted :
    08/17/2022
    Initiation :
    03/01/2019
    Primary completion :
    06/30/2020
    Completion :
    01/29/2024
    BRCA • MUC16
    |
    Avastin (bevacizumab) • Lynparza (olaparib) • Imfinzi (durvalumab) • Equidacent (bevacizumab biosimilar)